TrialSchizophrenia research2017

A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.

L Fredrik Jarskog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.